Akira Endo (1933-2024) Obituary – Cause of Death : “Japanese Biochemist, Pioneer in Statin Development Passes Away”

It is with great sadness that we report the passing of Akira Endo, a pioneering biochemist whose groundbreaking work on fungal extracts revolutionized the field of medicine. Endo, whose research led to the development of the first statin, a drug that has saved countless lives by lowering LDL cholesterol levels, passed away on 5 June 2024.

Endo’s contributions to the field of biochemistry have had a profound impact on public health worldwide. His discovery of the cholesterol-lowering properties of statins has been instrumental in the prevention and treatment of cardiovascular disease, which remains a leading cause of death globally.

Born on 14 November 1933 in Japan, Endo dedicated his career to studying the mechanisms of cholesterol metabolism and the role of fungal compounds in regulating cholesterol levels. His pioneering research paved the way for the development of statins, which are now among the most widely prescribed medications in the world.

Endo’s work has been recognized with numerous awards and accolades, including the prestigious Japan Prize in 2006. He was also a member of several scientific societies and served as a mentor to countless aspiring biochemists.

The news of Endo’s passing has been met with an outpouring of tributes from colleagues, friends, and admirers around the world. His legacy as a trailblazer in the field of biochemistry will continue to inspire future generations of researchers and medical professionals.

At this time, the cause of Endo’s death has not been publicly disclosed. The world has lost a true visionary and pioneer in the field of biochemistry, but his contributions to science and medicine will live on for generations to come.

Rest in peace, Akira Endo. Your work has left an indelible mark on the world, and your legacy will never be forgotten.